Streamline Health Solutions (STRM) Reports In-Line Q2 EPS

Streamline Health Solutions (NASDAQ: STRM) reported Q2 EPS of ($0.07), in-line with the analyst estimate of ($0.07). Revenue for the quarter came in at $5.99 million versus the consensus estimate of $5.2 million.

For earnings history and earnings-related data on Streamline Health Solutions (STRM) click here.

You May Also Be Interested In

• Synopsys upgraded at Piper Sandler on Intel foundry momentum, Apple opportunity
• Amylyx ALS drug shows no serious adverse events in Phase 1 trial
• BofA lists top 5 themes driving next $1tn in incremental semi sales